Core Laboratories (CLB) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Core Lab Reports Second Quarter 2021 Results From Continuing Operations:
July 28, 2021 5:15 PM EDTAMSTERDAM, July 28, 2021 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported second quarter 2021 revenue of $118,700,000. Core's operating income was $12,800,000, with earnings per diluted share ("EPS") of $0.17, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $13,200,000, yielding operating margins of 11% and EPS, ex-items, of $0.18. Year-over-year and sequential financial improvements are attributed to a continuation of U.S. onshore activity growth and market penetration, along with an improving landscape for Core's international operations. A full reconciliation of... More
